肝素类化合物与肿瘤的关系  

The relationship between heparin-like compounds and tumor

作　　者：张琳[1] 姬胜利[1] 谢美霞 

机构地区：[1]山东大学药学院生化与生物技术研究所,山东济南250012 [2]山东水利工程总公司,山东济南250014

出　　处：《食品与药品》2005年第04A期13-16,共4页Food and Drug

摘　　要：目的　综述肝素类化合物与肿瘤的关系。方法　查阅国内外相关文献,进行归纳总结。结果　肝素类化合物具有抑制肿瘤转移和肿瘤部位新生血管生成的作用。结论　肝素类化合物有望成为一种新型抗肿瘤药物。Objective To review the relationship between heparin-like compounds and tumor. Methods Refer to retrieve related documents, analyze and make a conclusion. Results Heparin-like compounds can inhibit tumor metastasis and angiogenesis. Conculusion It is promising to develop heparin-like compounds to a kind of novel anti-tumor drug.

关 键 词：低分子量肝素 硫酸乙酰肝素 多胺 肿瘤转移 

分 类 号：R979.14[医药卫生—药品]